alpha deficiency associated pulmonary emphysema liver cirrhosis pathogenesis treatment reviewed particular emphasis gene therapy emphysema technology gene transfer using viruses liposomes developing fast animal experiments confirmed feasibility gene therapy alpha deficiency aatd far subtherapeutic levels protein produced human trials starting progress expected NUMBER antitrypsin NUMBER antitrypsin